Abstract
Background
Gastroesophageal reflux disease (GERD) and dyspepsia are highly prevalent in the general population with significant symptom overlap, while the interaction between both remains poorly understood.
Aim
To examine whether GERD overlapping dyspepsia would have an impact on clinical and psychological features as compared with GERD alone.
Methods
We performed a cross-sectional study in a GERD cohort (n = 868) that was previously recruited from a population-based GERD survey (n = 2752). We compared the clinical and psychological factors between patients with and without dyspeptic symptoms “epigastric pain or burning.” All participants were evaluated with Reflux Disease Questionnaire score, Pittsburgh Sleep Quality Index score, Taiwanese Depression Questionnaire score, and State-Trait Anxiety Inventory score. Endoscopic findings were classified according to the Los Angeles classification.
Results
Among the GERD population, 107 subjects had overlapping “epigastric pain or burning” (GERD-D), and 761 did not have these symptoms (GERD alone). GERD-D subjects had more severe GERD symptoms and were more often associated with irritable bowel syndrome (IBS) (OR 3.54, 95% CI 1.92–6.52) as compared subjects with GERD alone. In addition, GERD-D subjects had lower quality of sleep (OR 1.11, 95% CI 1.01–1.21), higher depression (OR 1.06, 95% CI 1.02–1.10), lower blood pressure (OR 0.45, 95% CI 0.22–0.95), and higher serum total cholesterol levels (OR 2.78, 95% CI 1.36–5.67) than GERD alone.
Conclusions
GERD-D subjects are characterized with worsening clinical symptoms as well as higher psychosocial, IBS, and metabolic comorbidities, but less erosive esophagitis. Our results indicate that clinical awareness of such overlapping condition would help optimize the management of GERD in clinical practice.
Similar content being viewed by others
Abbreviations
- GERD:
-
Gastroesophageal reflux disease
- IBS:
-
Irritable bowel syndrome
- MS:
-
Metabolic syndrome
- LA grade:
-
Los Angeles classification system grade
- RDQ:
-
Reflux Disease Diagnostic Questionnaire
- PSQI:
-
Pittsburgh Sleep Quality Index score
- TDQ:
-
Taiwanese Depression Questionnaire score
- STAI:
-
State-Trait Anxiety Inventory score
- WHR:
-
Wait-to-hip ratio
- BMI:
-
Body mass index
- EE:
-
Erosive oesophagitis
- IR:
-
Insulin resistance
- NSAIDs:
-
Nonsteroidal anti-inflammatory drugs
- PPIs:
-
Proton pump inhibitors
- H2RAs:
-
Histamine-2 receptor antagonists
- AC:
-
Serum fasting blood glucose
- HbA1c:
-
Hemoglobin A1c
- TG:
-
Triglyceride
- TC:
-
Total cholesterol
- LDL:
-
Low-density lipoprotein
- HDL:
-
High-density lipoprotein
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- SBP:
-
Systolic blood pressure
- DBP:
-
Diastolic blood pressure
References
Tack J, Becher A, Mulligan C, et al. Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment Pharmacol Ther. 2012;35:1257–1266.
Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511.
Lee YC, Yen AM, Tai JJ, et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut. 2009;58:174–181.
Goh KL. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges. J Gastroenterol Hepatol. 2011;26:2–10.
Lee YC, Wang HP, Chiu HM, et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol. 2006;21:798–804.
Lei WY, Yu HC, Wen SH, et al. Predictive factors of silent reflux in subjects with erosive esophagitis. Dig Liver Dis. 2015;47:24–29.
Hsu CS, Liu TT, Wen SH, et al. Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2015;27:516–522.
Ford AC, Forman D, Bailey AG, et al. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol. 2008;103:1229–1239. (quiz 40).
Kennedy TM, Jones RH, Hungin AP, et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut. 1998;43:770–774.
Lovell RM, Ford AC. Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis. Am J Gastroenterol. 2012;107:1793–1801. (quiz 802).
Miwa H, Ghoshal UC, Gonlachanvit S, et al. Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil. 2012;18:150–168.
Park H. Functional gastrointestinal disorders and overlap syndrome in Korea. J Gastroenterol Hepatol. 2011;26:12–14.
Ghoshal UC, Singh R, Chang FY, et al. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil. 2011;17:235–244.
Manabe N, Haruma K, Hata J, et al. Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand J Gastroenterol. 2010;45:567–572.
Kitapcioglu G, Mandiracioglu A, Caymaz Bor C, et al. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community. Turk J Gastroenterol. 2007;18:14–19.
Lee SY, Lee KJ, Kim SJ, et al. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 2009;79:196–201.
Yarandi SS, Christie J. Functional dyspepsia in review: pathophysiology and challenges in the diagnosis and management due to coexisting gastroesophageal reflux disease and irritable bowel syndrome. Gastroenterol Res Pract. 2013;2013:351086.
Cao Y, Yan X, Ma XQ, et al. Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol. 2008;8:37.
Hsu CS, Liu WL, Chao YC, et al. Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection. Hepatol Int. 2015;9:231–242.
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–1390.
Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
Lee Y, Yang MJ, Lai TJ, et al. Development of the Taiwanese Depression Questionnaire. Chang Gung Med J. 2000;23:688–694.
Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res. 2011;63:S467–S472.
Hsu CS, Wang CC, Wang PC, et al. Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection. Hepatol Int. 2010;4:585–593.
Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92.
Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:52–57.
Wang PC, Hsu CS, Tseng TC, et al. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis. J Gastroenterol Hepatol. 2012;27:586–591.
Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438.
Hsu CS, Wang PC, Chen JH, et al. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:994–1004.
Gwee KA, Bak YT, Ghoshal UC, et al. Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25:1189–1205.
Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–406.
Mahadeva S, Goh KL. Anxiety, depression and quality of life differences between functional and organic dyspepsia. J Gastroenterol Hepatol. 2011;26:49–52.
Hartono JL, Mahadeva S, Goh KL. Anxiety and depression in various functional gastrointestinal disorders: do differences exist? J Dig Dis. 2012;13:252–257.
Ford AC, Forman D, Bailey AG, et al. The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study. Aliment Pharmacol Ther. 2013;37:323–331.
Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009;24:1601–1607.
Gwee KA, Wee S, Wong ML, et al. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol. 2004;99:924–931.
Greten H, Beil FU, Schneider J, et al. Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate. Am J Med. 1994;96:55S–63S.
Gudlaugsdottir S, Verschuren W, Dees J, et al. Hypertension is frequently present in patients with reflux esophagitis or Barrett’s esophagus but not in those with non-ulcer dyspepsia. Eur J Intern Med. 2002;13:369.
Anderson LA, Cantwell MM, Watson RG, et al. The association between alcohol and reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Gastroenterology. 2009;136:799–805.
Halder SL, Locke GR III, Schleck CD, et al. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil. 2006;18:1001–1008.
Acknowledgments
We thank all of whom helped to enroll and follow the study subjects. We are also grateful to the research assistants who assisted in laboratory analyses and collected clinical information. Finally, we would like to thank the anonymous reviewers and the editor for their constructive comments. All authors approved the final version of the article, including the authorship list.
Authors’ contributions
C-LC was involved in study concept and design. J-SH, T-TL, C-HY, W-YL, and C-LC were involved in acquisition of data. C-SH, S-HW, J-SH, and C-LC were involved in analysis and interpretation of data. C-SH, S-HW, J-SH, and C-LC drafted the manuscript. C-SH, S-HW, FP, and C-LC were involved in critical revision of the manuscript for important intellectual content. S-HW was involved in statistical analysis. C-SH and C-LC obtained the funding. C-SH, S-HW, and C-LC were involved in administrative, technical, or material support. C-LC was involved in study supervision.
Sources of funding and grant support
C-SH, S-HW, and C-LC had financial support from Hualien Tzu Chi Hospital and Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. This work was supported by grants from the Hualien Tzu Chi Hospital and Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-106-RT-8, TCRD-TPE-104-31, TCMMP104-02-01, TCMMP104-02-02, TCMMP104-02-03).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no other potential conflicts (financial, professional, or personal) that are relevant to the manuscript.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hsu, CS., Wen, SH., Hung, JS. et al. Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics. Dig Dis Sci 62, 994–1001 (2017). https://doi.org/10.1007/s10620-017-4455-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-017-4455-8